FULCRUM THERAPEUTICS, INC. (FULC) Free cash flow 2018–2025
FULCRUM THERAPEUTICS, INC. (FULC) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$60.4MFY2025 · since FY2018: -$31.5M → -$60.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$60.4M | -2319.0% |
| FY2024 | -$2.5M | +97.3% |
| FY2023 | -$91.5M | +7.6% |
| FY2022 | -$99.0M | -23.5% |
| FY2021 | -$80.2M | -45.8% |
| FY2020 | -$55.0M | -36.3% |
| FY2019 | -$40.3M | -27.9% |
| FY2018 | -$31.5M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice